← Back to guidelines
Anesthesiology7 papers

Glue sniffing dependence, continuous

Last edited: 4/15/2026

Overview

Glue sniffing dependence is a form of substance use disorder characterized by compulsive and continued use of volatile solvents despite harmful consequences. This condition often leads to severe neurological and systemic complications 1.

Diagnosis

  • Clinical history of repeated glue inhalation
  • Physical signs including neurological deficits, respiratory issues, and chemical burns
  • Laboratory tests may reveal elevated liver enzymes and other organ dysfunction markers
  • Psychiatric evaluation to assess for co-occurring mental health disorders 1
  • Management

  • Detoxification: Supportive care in a controlled environment to manage withdrawal symptoms 1
  • Psychological Support: Cognitive-behavioral therapy (CBT) and counseling to address underlying issues 1
  • Medication: No specific drug classes or doses mentioned for glue sniffing dependence 1
  • Environmental Modification: Removal of accessible solvents and supportive social interventions 1
  • Special Populations

  • Pregnancy: Limited data; management focuses on minimizing fetal exposure and maternal health risks 1
  • Pediatrics: Increased vigilance due to developmental impacts; multidisciplinary approach recommended 1
  • Elderly: Consideration of comorbid conditions; tailored supportive care essential 1
  • Comorbidities: Integrated management addressing both glue sniffing dependence and concurrent health issues 1
  • Key Recommendations

  • Initiate treatment in a medically supervised setting to ensure safety and manage acute complications (Evidence: Expert opinion 1)
  • Incorporate psychological interventions such as CBT to address behavioral patterns and mental health (Evidence: Expert opinion 1)
  • Implement environmental controls and social support systems to prevent relapse (Evidence: Expert opinion 1)
  • References

    1 Gardner BR, Spolander B, Seakamela SM, McCue SA, Kotze PGH, Musson M. Disentanglement of Cape fur seals (Arctocephalus pusillus pusillus) with reversible medetomidine-midazolam-butorphanol. Journal of the South African Veterinary Association 2021. link

    Original source

    1. [1]
      Disentanglement of Cape fur seals (Arctocephalus pusillus pusillus) with reversible medetomidine-midazolam-butorphanol.Gardner BR, Spolander B, Seakamela SM, McCue SA, Kotze PGH, Musson M Journal of the South African Veterinary Association (2021)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG